IL6R and cholangiocarcinoma: In this study, we aimed at investigating the roles of CCA-derived CAFs on gemcitabine resistance in CCA cells and the inhibition of CAF-CCA interactions by blocking IL-6R on CCA cells to enhance gemcitabine sensitivity.